Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Galectin Therapeutics Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 73 | 4 | 79 | +10 |
| Shares | 9.52M | 1.58M | 9.75M | +1.81M (+22.8%) |
| Value | $21.6M | $3.57M | $26.8M | +$8.74M (+48.4%) |
4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,607,124 | $4.42M | 0.00% |
| Soltis Investment Advisors LLC | 140,750 | $387.1K | 0.04% |
| Kovitz Investment Group Partners, LLC | 42,540 | $117.0K | 0.00% |
| ExodusPoint Capital Management, LP | 29,552 | $81.0K | 0.00% |
| Gladstone Institutional Advisory LLC | 21,750 | $59.8K | 0.00% |
| Colony Group, LLC | 16,734 | $46.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,173 | $30.7K | 0.00% |
| Oarsman Capital, Inc. | 9,698 | $26.7K | 0.00% |
| CoreCap Advisors, LLC | 7,695 | $21.2K | 0.00% |
| Larson Financial Group LLC | 1,300 | $3.58K | 0.00% |
| Russell Investments Group, Ltd. | 740 | $2.04K | 0.00% |
| FMR LLC | 182 | $501 | 0.00% |
| Sterling Capital Management LLC | 38 | $105 | 0.00% |
| CWM, LLC | 170 | $0 | 0.00% |
Sold out (4)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Alpine Global Management, LLC | 19,555 | $44.2K |
| Connor, Clark & Lunn Investment Management Ltd. | 16,611 | $37.5K |
| Virtu Financial LLC | 11,233 | $25.0K |
| Citadel Advisors LLC | 823 | $1.86K |
Not filed for Q3 2024 yet (4)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,563,783 | $3.53M |
| Buckingham Strategic Wealth, LLC | 13,234 | $29.9K |
| Benjamin F. Edwards & Company, Inc. | 1,775 | $4.00K |
| Bradley & Co. Private Wealth Management, LLC | 1,000 | $2.26K |